HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chimeric pestiviruses: candidates for live-attenuated classical swine fever marker vaccines.

Abstract
The use of attenuated classical swine fever virus (CSFV) strains as live vaccines is no longer allowed for the control of classical swine fever in Europe, due to the inability to differentiate between infected and vaccinated animals (Differentiating Infected from Vaccinated Animals; DIVA), except as emergency vaccines or as bait vaccines for wild boars. Thus, the establishment of a DIVA vaccine(s) is of pivotal importance for the control of this infectious disease. In this study, recombinant versions of the live-attenuated vaccine strain CSFV Riems were generated by replacing parts of the E2 gene with the corresponding sequence of border disease virus strain Gifhorn. Three cDNA clones were constructed: pRiems-ABC-Gif, pRiems-A-Gif and pRiems-BC-Gif. Infectious particles were obtained from clones pRiems-ABC-Gif and pRiems-BC-Gif only, whereas transfected RNA from clone pRiems-A-Gif behaved like a replicon. Based on its ability to be differentiated in vitro from wild-type CSFV by mAbs, vRiems-ABC-Gif was assessed for immunogenicity and protection against challenge infection in pigs. Before challenge, no CSFV-specific anti-E2 antibodies could be detected with commercial E2-blocking ELISAs in vRiems-ABC-Gif-vaccinated animals, whereas vRiems-vaccinated pigs developed high titres of anti-E2 antibodies, confirming the marker properties of this vaccine candidate. After oral vaccination, only partial protection against challenge infection was observed in the vRiems-ABC-Gif vaccinees, whereas all intramuscularly vaccinated animals and all vRiems-vaccinated animals were fully protected. These experiments suggest that the strategy of exchanging specific antigenic epitopes among pestiviruses is a promising tool for the development of new CSFV marker vaccines.
AuthorsFranziska Wehrle, Sandra Renzullo, Anja Faust, Martin Beer, Volker Kaden, Martin A Hofmann
JournalThe Journal of general virology (J Gen Virol) Vol. 88 Issue Pt 8 Pg. 2247-2258 (Aug 2007) ISSN: 0022-1317 [Print] England
PMID17622629 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Epitopes
  • Glycoproteins
  • Vaccines, Attenuated
  • Viral Structural Proteins
  • Viral Vaccines
  • glycoprotein E2, border disease virus
Topics
  • Administration, Oral
  • Animals
  • Antibodies, Viral (blood)
  • Antibody Specificity
  • Border disease virus (chemistry, immunology, metabolism)
  • Cell Line
  • Classical Swine Fever (immunology, prevention & control)
  • Classical Swine Fever Virus (genetics, immunology, metabolism)
  • Drug Evaluation, Preclinical
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes (genetics, immunology)
  • Genes, Viral (genetics)
  • Glycoproteins (biosynthesis, genetics, immunology)
  • Injections, Intramuscular
  • Reassortant Viruses (immunology, metabolism)
  • Swine
  • Vaccination
  • Vaccines, Attenuated (administration & dosage, genetics)
  • Viral Structural Proteins (biosynthesis, genetics, immunology)
  • Viral Vaccines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: